HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

Published:2006-07 Issue:1 Volume:10 Page:25-38
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Wang Shizhen Emily,Narasanna Archana,Perez-Torres Marianela,Xiang Bin,Wu Frederick Y.,Yang Seungchan,Carpenter Graham,Gazdar Adi F.,Muthuswamy Senthil K.,Arteaga Carlos L.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference54 articles.

1. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth;Agus;Cancer Cell,2002

2. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas;Alimandi;Oncogene,1995

3. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function;Biscardi;J. Biol. Chem.,1999

4. Increased HER2 gene copy number is associated with response to gefitinib therapy in epidermal growth factor receptor-positive non-small-cell lung cancer patients;Cappuzzo;J. Clin. Oncol.,2005

5. Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy;Citri;EMBO J.,2002

Cited by 399 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Measurement of HER2 Expression in Non–Small Cell Lung Cancer With a High-Sensitivity Assay;Modern Pathology;2024-09

2. HER3 receptor and its role in the therapeutic management of metastatic breast cancer;Journal of Translational Medicine;2024-07-17

3. The rapidly changing field of predictive biomarkers of non-small cell lung cancer;Pathology and Oncology Research;2024-06-17

4. Discovery of Novel 5,6-Dihydro-4H-pyrido[2,3,4-de]quinazoline Irreversible Inhibitors Targeting Both Wild-Type and A775_G776insYVMA Mutated HER2 Kinases;Journal of Medicinal Chemistry;2024-03-22

5. Widespread alteration of protein autoinhibition in human cancers;Cell Systems;2024-03